The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people
hospitalized with severe COVID-19 illness has engendered considerable interest in the …

Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more
protective than vaccination or previous infection alone. To investigate the kinetics of spike …

Background Characterizing the kinetics of the antibody response to severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) is of critical importance to developing strategies …

BACKGROUND Measuring the immune response to SARS-CoV-2 enables assessment of
past infection and protective immunity. SARS-CoV-2 infection induces humoral and T cell …

SARS-CoV-2 neutralising antibodies provide protection against COVID-19. Evidence from
early vaccine trials suggested binding antibody thresholds could serve as surrogate markers …

With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative
anti-spike protein serological testing will likely become increasingly important. Here, we …

SARS-CoV-2 serum neutralization assay represents the gold standard for assessing
antibody-mediated protection in naturally infected and vaccinated individuals. In the present …

Background Understanding the long-term kinetic characteristics of SARS-CoV-2 antibodies
and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has now caused over 2 million …